Silver Book Fact

The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.

Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. May 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
May 2011
Authors
Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • Over a 1-year period, 54% of individuals with age-related macular degeneration (AMD) reported a fall and 30% reported more than one.  Of all reported falls, 63% resulted in an injury.  
  • Glaucoma accounts for more than 7 million physician visits each year.  
  • Age-related macular degeneration (AMD) is the leading cause of blindness among white Americans– accounting for 54% of cases of blindness.  
  • It is estimated that those aged 50 years or older with macular degeneration will double– 9 million to 18 million– by 2050.  
  • More than 2.1 million Americans age 80 and older have low vision or are blind– 23.7% of the 80 and older population.